| Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394) |
|---|
| 03/29/2006 | CN1247572C Method of producing nitroguanidine-and nitroenamine derivatives |
| 03/29/2006 | CN1247536C Process for preparing guanidine hydrochloride |
| 03/28/2006 | CA2125104C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/23/2006 | WO2004087057A3 Methods for inhibition of angiogenesis |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/22/2006 | EP1636173A2 Ionic liquids containing guanidinium cations |
| 03/22/2006 | CN1246306C New method for preparing brufen arginine salt |
| 03/21/2006 | US7015019 1-O-L-arginyl ester 3-O-monoacyl glycerides and 1-O-L-arginyl ester 2,3-O-diacyl glycerides type surface active agents |
| 03/16/2006 | US20060058530 Amidine substituted aryl aniline compounds |
| 03/16/2006 | US20060057194 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy |
| 03/15/2006 | CN1747984A Polymer guanidine derivatives as a cytostatic medicament |
| 03/09/2006 | US20060052372 N-(Heterocycloalkyl)alkylsulfonamides, e.g., N-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-N-(4-methoxyphenyl)-propanesulfonamide; improve blood flow to the optic nerve head and the retina ; used to treat retinal diseases, sleep disorders, depression, schizophrenia, anxiety, OCD, etc. |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1294678B1 Process for the preparation of cationic surfactants |
| 03/02/2006 | WO2006023586A2 Guanylhydrazone compounds, compositions, methods of making and using |
| 03/01/2006 | EP1630212A1 Ink composition and inkjet recording method |
| 02/28/2006 | US7005141 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres. |
| 02/23/2006 | US20060041024 Polycationic compounds and uses thereof |
| 02/22/2006 | CN1738794A Biguanide and dihydrotriazine derivatives |
| 02/21/2006 | US7002042 Cationic liposomes for gene transfer |
| 02/21/2006 | US7001924 Inhibitors of RNase P proteins as antibacterial compounds |
| 02/21/2006 | US7001606 Biocidal polymers based on guanidine salts |
| 02/21/2006 | CA2453080C Polyene polyketides, processes for their production and their use as a pharmaceutical |
| 02/21/2006 | CA2184691C L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
| 02/15/2006 | EP1154767B1 Substituted stilbene compounds with vascular damaging activity |
| 02/15/2006 | CN1733707A Compounds and methods for synthesis and therapy |
| 02/08/2006 | CN1732146A Cycloalkyl inhibitors of potassium channel function |
| 02/08/2006 | CN1240676C Process for producing ethyl creatine ester hydrochloride |
| 02/07/2006 | US6995269 Guanidinobenzamides |
| 02/02/2006 | WO2006010422A1 Guanidine derivatives and therapeutic uses thereof |
| 02/02/2006 | WO2005123660A3 Polycationic compounds and uses thereof |
| 02/02/2006 | US20060025614 E.g., N-2-(4-chlorophenyl)-N-(1-{[N-cyano-2-(2-methylphenyl) ethanimidoyl]amino}-2,2-dimethylpropyl)acetamide and N'-cyano-2-(2-methylphenyl)-N-[(1R)-1-phenylethyl]ethanimidamide; useful for treating conditions such as pain, inflammation and neurodegeneration states |
| 02/02/2006 | DE102004033021A1 Liquid pressure transmitting medium, useful in hydraulic component or machines, comprises ionic liquid as pressure transmitting medium |
| 02/02/2006 | CA2574947A1 Guanidine derivatives and therapeutic uses thereof |
| 02/01/2006 | CN1729172A Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity |
| 02/01/2006 | CN1239476C Technique for picking up total alkali of motherwort |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | CN1724514A Preparation method of L-homoarginine hydrochloride |
| 01/23/2006 | CA2586086A1 Furin inhibitors |
| 01/19/2006 | US20060014833 Bioavailability, water solubility |
| 01/12/2006 | WO2006004613A2 Guanylhydrazone salts, compositions, processes of making and methods of using |
| 01/11/2006 | EP1613319A2 Substituted phenyl acetamides and their use as protease inhibitors |
| 01/11/2006 | EP1613268A2 Methods for inhibition of angiogenesis |
| 01/11/2006 | EP1328577B1 Method and compositions |
| 01/11/2006 | CN1235876C Prepn of guanidyl thiocyanate |
| 01/05/2006 | WO2006000756A1 Sanitizing composition |
| 01/05/2006 | CA2572259A1 Sanitizing composition |
| 01/03/2006 | CA2156289C Drug composition containing nucleic acid copolymer |
| 12/29/2005 | WO2005123700A1 Small molecules for treatment of hypercholesterolemia and related diseases |
| 12/29/2005 | WO2005123676A1 Bi- or tetra-guanidino-biphenyl compounds as small molecule carriers |
| 12/29/2005 | WO2005123660A2 Polycationic compounds and uses thereof |
| 12/29/2005 | WO2005123646A2 Fluoroorganic compounds and anti-fouling treatments |
| 12/29/2005 | US20050287108 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof |
| 12/29/2005 | CA2570258A1 Bi- or tetra-guanidino-biphenyl compounds as small molecule carriers |
| 12/29/2005 | CA2570248A1 Polycationic compounds and uses thereof |
| 12/29/2005 | CA2568539A1 Small molecules for treatment of hypercholesterolemia and related diseases |
| 12/28/2005 | EP1265867B1 Malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 12/15/2005 | US20050277690 Small molecules for treatment of hypercholesterolemia and related diseases |
| 12/14/2005 | EP1224165B1 Novel compounds |
| 12/13/2005 | US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders |
| 12/06/2005 | US6972281 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof |
| 12/01/2005 | WO2005095345A3 Heteroaryl guanidines as inhibitors of viral replication |
| 12/01/2005 | US20050266520 Process for the synthesis of peptides |
| 11/30/2005 | CN1229362C Bicyclic guanidine derivatives and therapeutic uses thereof |
| 11/24/2005 | US20050260597 Transfection reagents |
| 11/17/2005 | US20050256201 Phenethanolamine derivatives |
| 11/17/2005 | US20050255138 Active agent transport systems |
| 11/16/2005 | CN1697828A New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 11/16/2005 | CN1227219C Biocidal polymers based on guanidine salts |
| 11/15/2005 | CA2130944C Ortho-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them |
| 11/15/2005 | CA2130031C Urea-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them |
| 11/15/2005 | CA2111512C 3,5-substituted aminobenzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 11/10/2005 | WO2005105152A2 Lipids, lipid complexes and use thereof |
| 11/10/2005 | WO2005041924A3 Administration of levodopa and carbidopa |
| 11/10/2005 | US20050250962 Production process of dicreatine malate |
| 11/10/2005 | CA2565633A1 Lipids, lipid complexes and use thereof |
| 11/09/2005 | EP1019365B1 Novel compositions for the delivery of negatively charged molecules |
| 11/09/2005 | EP0844874B1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS |
| 11/08/2005 | US6963011 Central nervous system disorders; psychological disorders |
| 11/02/2005 | EP1159261B1 Antizyme modulators and their use |
| 11/01/2005 | US6960689 Method for preparing nitrogen-containing compounds |
| 11/01/2005 | US6960681 Guanidinomethyl cyclohexane carboxylic acid ester derivatives |
| 10/27/2005 | WO2005100306A1 N, n’, n’’-tris-(3-dimethylaminopropyl)-guanidine. the procedure of preparation from carbodiimide and application in reactions of transesterification of oil |
| 10/27/2005 | WO2005100298A1 Cetp inhibitors |
| 10/27/2005 | CA2562082A1 Cetp inhibitors for the treatment and prevention of atherosclerosis |
| 10/20/2005 | WO2005097713A1 Fluoridation method |
| 10/20/2005 | US20050234232 Novel compositions for the delivery of negatively charged molecules |
| 10/20/2005 | US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders |
| 10/20/2005 | US20050233953 Histogranin-like peptides, processes for their preparation and uses thereof |
| 10/19/2005 | EP1585752A1 Polyene polyketides, processes for their production and their use as a pharmaceutical |
| 10/19/2005 | CN1683327A Process for synthesizing dicreatine malic acid |
| 10/18/2005 | CA2156288C Glycerol derivative, device and pharmaceutical composition |
| 10/13/2005 | WO2005095345A2 Heteroaryl guanidines as inhibitors of viral replication |
| 10/13/2005 | US20050228017 Novel anticancer compounds |
| 10/06/2005 | US20050221368 Methods for identifying RNA binding compounds |
| 10/05/2005 | EP1500595A4 Method for protecting packed food products from spoilage during storage and package or pre-cut package for storing food products |
| 09/29/2005 | WO2005089734A2 Creatine salt enhanced nutritional and therapeutic efficacy and compositions containing same |
| 09/29/2005 | WO2005041925A3 Compositions and dosage forms for enhanced absorption |
| 09/29/2005 | US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate |
| 09/29/2005 | US20050215642 Aromatic guanidine compound; antitumor agents; anticancer agents; for the treatment of breast cancer |